The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells
Open Access
- 1 January 2014
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 61 (1) , 41-53
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 22 references indexed in Scilit:
- Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor modelsEndocrine-Related Cancer, 2012
- Human adrenocortical carcinoma cell linesMolecular and Cellular Endocrinology, 2012
- Approach to the Patient with Adrenocortical CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2010
- EverolimusClinical Cancer Research, 2010
- Na+/K+‐ATPase‐mediated signal transduction and Na+/K+‐ATPase regulationFundamental & Clinical Pharmacology, 2008
- Antiproliferative Activity of Derivatives of Ouabain, Digoxin and Proscillaridin A in Human MCF-7 and MDA-MB-231 Breast Cancer CellsBiological and Pharmaceutical Bulletin, 2008
- Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic LeukemiaClinical Chemistry, 2007
- Proteomics Analysis of the Proliferative Effect of Low-Dose Ouabain on Human Endothelial CellsBiological and Pharmaceutical Bulletin, 2007
- Is digitalis a therapy for breast carcinoma?Oncology Reports, 1999
- Cardiac Glycosides and Breast Cancer, RevisitedNew England Journal of Medicine, 1982